Gem Aromatics Ltd

- The transcript and information on page 19 (and surrounding pages) do not mention any current or planned fundraising through debt or equity for GEM Aromatics Limited. - No specific details were provided about raising new capital via debt or equity instruments during the discussed period. - The focus is on revenue growth, capacity ramp-up at Dahej, margin improvement, and product diversification rather than capital raising. - The company appears to be funding its ongoing capex (approximately INR270 crores for Dahej) through internal accruals and existing resources, as no mention of external fundraising was made. - If you need detailed or updated fundraising plans, it is advisable to contact the investor relations team at Stellar Investor Relations as suggested in the document.

- The company has invested approximately INR 250 crores in the new Dahej facility (Krystal Ingredients), with INR 20-25 crores remaining to be spent. - The Dahej facility is designed as a flexible multipurpose manufacturing platform, supporting rapid product transitions and improved asset utilization. - The asset turnover target for the Dahej plant is 3x, aiming for INR 750 to INR 800 crores revenue by FY '29 at peak utilization. - The ramp-up plan targets 50%-60% utilization by Q1 FY '28, with all products expected to come online by Q1 FY '27. - Minimal additional capex is anticipated for optimizing the Dahej facility based on product mix and traction. - The company is also pursuing strategic moves such as consolidation of product lines (e.g., moving clove from GEM to Krystal) to enhance capital efficiency.

- GEM Aromatics targets revenue of INR1,050 to INR1,100 crores by FY’28 with an EBITDA margin of 16% to 18%. - The Dahej (Krystal) facility is expected to ramp up to 50%-60% utilization by Q1 FY’28 and potentially reach peak revenue of INR750 to INR800 crores by FY’29. - Krystal's contribution to revenue is projected at INR650 to INR700 crores with the balance from GEM, subject to product mix adjustments. - The existing GEM facility is expected to contribute around INR400 crores by FY’28, growing from a Q2/Q3 run-rate of INR320 crores. - Growth is backed by capacity ramp-up at Dahej, diversification of products, and expanding into institutional customers, especially in cooling agents. - Export recovery is expected with easing tariff impacts and new approvals in major markets like the US and Europe. - Overall, the company expects gradual improvement in demand, volume, and price realization supporting sustainable growth.

- The company targets revenue of INR 1,050 to INR 1,100 crores by FY’28 with EBITDA margins of 16% to 18% (Page 19). - EBITDA margins are expected to improve as the Krystal plant ramps up; currently, EBITDA margin is around 9% but is projected to increase with capacity utilization (Page 8). - Krystal plant is expected to achieve cash breakeven at approximately 45% utilization by next year (FY’27) (Page 10). - The Dahej facility (Krystal Ingredients) aims for INR 750 to 800 crores revenue by FY’29, with a 3x asset turnover and 30% free space for expansion (Page 11). - Ramp-up at Dahej facility to 50%-60% utilization is expected by Q1 FY’28, supporting revenue and margin growth (Page 9). - Gradual easing of near-term uncertainties like tariffs and GST issues is expected to support improved business momentum (Page 17). - Profit margins will benefit from a shift to higher-margin products and operational efficiencies at the new facility (Pages 8, 10-11).

- Q4 is historically the strongest quarter for order booking, especially from the US and export markets. - Customers have largely depleted inventories over Q2 and Q3, leading to increased inquiries and expected order flows in Q4. - The company anticipates a higher volume of orders compared to Q2 and Q3 but is cautious about exact numbers due to various market uncertainties. - The ramp-up in cooling agent sales is expected after audits complete by March-April, potentially adding to order inflows. - Overall, inquiries and order flows are improving, but timing of revenue recognition may be affected by export and accounting practices.